Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An esophageal carcinoma characterized by the presence of distinguishable squamous and glandular carcinomatous components.
Biomarker and diagnostic research for esophageal adenosquamous carcinoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
14 publications have been identified in PubMed for esophageal adenosquamous carcinoma. Research spans Diagnostic / Biomarker (23%), Case Report / Case Series (23%), and Epidemiology / Natural History (23%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 3 | 23% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:05 PM UTC
Patient case studies |
3 |
23% |
Disease patterns and progression | 3 | 23% |
Clinical study results | 2 | 15% |
Research summaries | 1 | 8% |
Laboratory research | 1 | 8% |
Husain KH (2026). [PMID: 42170170](https://pubmed.ncbi.nlm.nih.gov/42170170/). *ACG Case Rep J*. [Case Report / Case Series]
Xin X (2026). [PMID: 42151650](https://pubmed.ncbi.nlm.nih.gov/42151650/). *J Cancer Res Clin Oncol*. [Diagnostic / Biomarker]
Takeuchi H (2025). [PMID: 41101325](https://pubmed.ncbi.nlm.nih.gov/41101325/). *Lancet Gastroenterol Hepatol*. [Clinical Trial Publication]
Liu GJ (2025). [PMID: 40092933](https://pubmed.ncbi.nlm.nih.gov/40092933/). *World J Gastrointest Oncol*. [Case Report / Case Series]
Xu Z (2025). [PMID: 41399180](https://pubmed.ncbi.nlm.nih.gov/41399180/). *Int J Surg*. [Epidemiology / Natural History]
Lyu SI (2025). [PMID: 40634392](https://pubmed.ncbi.nlm.nih.gov/40634392/). *Sci Rep*. [Basic Science / Preclinical]
Aoyama T (2025). [PMID: 41151906](https://pubmed.ncbi.nlm.nih.gov/41151906/). *Anticancer Res*. [Diagnostic / Biomarker]
Vasconcelos AC (2025). [PMID: 41409551](https://pubmed.ncbi.nlm.nih.gov/41409551/). *GE Port J Gastroenterol*. [Review / Meta-Analysis]
Liu K (2025). [PMID: 40961854](https://pubmed.ncbi.nlm.nih.gov/40961854/). *Eur J Surg Oncol*. [Clinical Trial Publication]
C SA (2024). [PMID: 39176361](https://pubmed.ncbi.nlm.nih.gov/39176361/). *Cureus*. [Case Report / Case Series]
AI-curated news mentioning esophageal adenosquamous carcinoma
Updated Aug 25, 2026
A case report details esophageal adenosquamous carcinoma with mucinous carcinoma-predominant lymph node metastases, contributing to the understanding of this rare cancer type. This report may provide insights for future research and treatment approaches.